
| Serial Number | 99155723 |
| Word Mark | WYNBEXIA |
| Filing Date | Friday, April 25, 2025 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, February 3, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 9, 2025 |
| Goods and Services | Sanitary preparations for medical purposes; dietetic preparations adapted for medical purposes; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases of, generated from and affecting the central nervous system; pharmaceutical preparations and substances for treatment of central nervous system disorders; central nervous system stimulants; pharmaceutical preparations and substances for the diagnosis, prevention and treatment of psychiatric, neurological, neurohormonal, neurogenetic, neuroendocrinological and autoimmune diseases and disorders; pharmaceutical preparations and substances for diagnosis, prevention and treatment of dementia, Alzheimer's disease, depression, psychosis, anxiety, Lennox-Gastaut disease, epilepsy, Dravet Syndrome, Developmental and Epileptic Encephalopathy (DEE), alpha-synucleinopathies, Multiple System Atrophy (MSA), dementia with Lewy bodies, rapid eye movement (REM) sleep behavior syndrome, porphyria, Huntington's disease, insomnia, Parkinson's disease, sclerosis, multiple sclerosis, schizophrenia, bipolar disorder, cancer, pain, migraine, headache, Horton's headache, traumatic brain injury, post-traumatic brain injury, dizziness, seizures, stroke, cognitive impairment, cognitive disorders and diseases, mood disorders, falls, movement disorders and diseases, tremor, agitation, mania, aggression, autism, melancholia, Obsessive Compulsive Disorder (OCD), Tourette's syndrome, restlessness, akathisia, fatigue, somnolence, nausea, Cushing's disease, Adrenogenital syndrome (AGS), narcolepsy, Post-Traumatic Stress Disorder (PTSD), Attention Deficit Hyperactivity Disorder (ADHD), Progressive Supranuclear Palsy (PSP), Thyroid Associated Orbitopathy (TAO), Graves Orbitopathy, Hashimoto's Thyroiditis, alcoholism and addiction; diagnostic agents and preparations for medical purposes; chemical substances for diagnostic and medical purposes, namely, chemical reagents for medical use, diagnostic chemical reagents for medical purposes; medical diagnostic reagents |
| Goods and Services | Medical apparatus, namely, infusion and injection devices for administering drugs; syringes, intravenous bags, IV tubing, IV pumps, and IV catheters; injection devices for administering drugs, syringes and needles for injections and medical purposes; apparatus and instruments for diagnostic purposes, namely, dosage management dispensers for medicines and containing downloadable and recorded software for medical information management for use in web-based physical and psychological examination and assessment of patients at a distance and at a clinic; medical devices and instruments for use in the diagnosis, administration, monitoring, assessment, control and examination of psychiatric, neurological, neurohormonal, neurogenetic, neuroendocrinological and autoimmune disorders and diseases; integrated medical systems comprising of medical instruments for diagnostics and examination of patients and downloadable computer software for processing patient intake and communications and information management, all for use in the physical and psychological and neurological examination and assessment of patients and clients; integrated medical systems comprised of medical devices and instruments for treating central nervous system diseases and disorders and psychiatric, neurological, neurohormonal, neurogenetic, neuroendocrinological and autoimmune disorders and diseases, all for the purposes of management, measurement, monitoring, evaluation, control, collection, storage, transmission and examination of patient and client data and information; medical instruments for providing medication administering information, guidance, management in the nature of devices for delivery and administering of medicines and infusion pumps |
| Translation of Words in Mark | The wording WYNBEXIA has no meaning in a foreign language. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 25, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 25, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Longboard Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | La Jolla, CA 92037 |
| Party Name | Longboard Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | La Jolla, CA 92037 |
| Event Date | Event Description |
| Friday, April 25, 2025 | NEW APPLICATION ENTERED |
| Friday, April 25, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 25, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, September 16, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, September 17, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 17, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 17, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, September 25, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, September 25, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 25, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, October 13, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, October 13, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, October 13, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, November 12, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, November 12, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, November 12, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, November 12, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, November 12, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 12, 2025 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Wednesday, November 12, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, November 12, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, November 12, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, November 12, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, November 12, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 3, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 9, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 9, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 3, 2026 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |